SR cap: Each sustained released capsule contains: Ambroxol Hydrochloride 75 mg.
Tab: Each Zobrixol tablet contains: Ambroxol hydrochloride 30 mg.
Syr: Each 5mL Zobrixol Syrup contains: Ambroxol hydrochloride 15 mg.
DS syr: Each 5mL Zobrixol DS contains: Ambroxol hydrochloride 30 mg.
Infant oral drops: Each mL Zobrixol Syrup Oral drops contains: Ambroxol hydrochloride 6 mg.
Zobrixol contains Ambroxol, which stimulates respiratory fluid secretion, resulting to a less sticky mucus. Ambroxol makes the mucus/phlegm easier to cough out and breathing is eased considerably.
This medicine is used for the relief of cough caused by acute and chronic disorder of the respiratory tract accompanied with thick and sticky mucus such as acute and chronic bronchitis, asthmatoid bronchitis and bronchial asthma.
SR cap: Adult and Children over 12 years should take 1 capsule once daily after meal with plenty of liquid (sufficient supply of liquid supports the expectorant effect of Zobrixol). Or as prescribed by the physician.
Tab: Children 6-12 yrs: 1/2 tablet 2-3 times daily.
Adults & children over 12 years: 1 tablet thrice a day for the first 2-3 days and then 1 tablet twice daily or ½ tablet thrice daily.
Syr: Children under 2 years: 2.5 mL twice a day.
Children 2-5 years: 2.5 mL thrice a day.
Children 6-12 years: 5 mL 2-3 times a day.
Adults & children over 12 years: 10 mL thrice daily during the first 2-3 days, then 10 mL twice daily or 5 mL thrice daily.
DS syr: Children 6-12 years: 2.5ml 2-3 times a day.
Adults & children over 12 years: 5 mL thrice a day for 2-3 days, then 5 mL twice daily or 2.5 mL thrice a day.
Infant oral drops: Children 6 months and under: 0.5 mL twice a day.
Children 7-12 months: 1 mL twice a day.
Children 13-24 months: 1.25 mL twice a day.
Missed dose: If the patient missed a dose, take the dose if still needed and subsequent doses at the usual recommended schedule. Do not exceed recommended dose.
Symptoms of Ambroxol overdose include extension of undesirable effects such as Gastro-intestinal disturbances (diarrhea, nausea, vomiting) and skin rashes.
If the patient is allergic to any component in the product.
Do not take more than the recommended dose.
Consult a physician if any adverse effect occurs.
Not recommended during the first three month of pregnancy.
If the patient has taken more than the recommended dosage, consult a physician.
Ambroxol is generally well tolerated. Gastro-intestinal disturbances (diarrhea, nausea, vomiting), transient rise in serum aminotransferase. In rare cases weakness, headache, and skin rash.
Ambroxol HCl (Zobrixol) should not be taken simultaneously with antitussive (e.g codeine), because it could lead to non-expectoration of phlegm or mucus previously liquified by Zobrixol.
Store at room temperature not exceeding 30°C.
R05CB06 - ambroxol ; Belongs to the class of mucolytics. Used in the treatment of wet cough.
Zobrixol SR cap 75 mg
50's (P1,440.2/pack)
Zobrixol Infant oral drops 6 mg/mL
15 mL x 1's (P74.85/bottle)
Zobrixol DS syr 30 mg/5 mL
60 mL x 1's (P114.8/bottle)
Zobrixol syr 15 mg/5 mL
120 mL x 1's;60 mL x 1's (P84.8/bottle)
Zobrixol tab 30 mg
100's (P1,043.3/pack)